US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist

0.415
+0.019+4.91%

Trading Jul 23 12:00 ET

86.01MMarket Cap-221P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-99.70%481K

58.34%176.23M

-92.50%2.04M

-64.48%9.4M

-76.73%6.84M

459.52%157.96M

0.54%111.3M

-2.70%27.23M

-7.36%26.46M

5.40%29.38M

Operating revenue

-99.70%481K

58.34%176.23M

-92.50%2.04M

-64.48%9.4M

-76.73%6.84M

459.52%157.96M

0.54%111.3M

-2.70%27.23M

-7.36%26.46M

5.40%29.38M

Cost of revenue

Gross profit

Operating expense

-41.42%47.66M

-5.55%295.22M

-22.77%63.81M

-12.72%71.01M

5.26%79.06M

10.70%81.35M

6.31%312.58M

21.71%82.62M

5.66%81.35M

-1.91%75.11M

Selling and administrative expenses

-35.12%11.77M

-2.42%61.17M

-20.34%13.1M

-14.29%13.92M

6.10%16.01M

21.65%18.14M

-0.85%62.68M

2.23%16.44M

11.98%16.24M

-8.45%15.09M

-General and administrative expense

-35.12%11.77M

-2.42%61.17M

-20.34%13.1M

-14.29%13.92M

6.10%16.01M

21.65%18.14M

-0.85%62.68M

2.23%16.44M

11.98%16.24M

-8.45%15.09M

Research and development costs

-43.22%35.89M

-6.34%234.06M

-23.38%50.71M

-12.33%57.09M

5.04%63.05M

7.91%63.22M

8.27%249.9M

27.76%66.18M

4.19%65.12M

-0.11%60.02M

Operating profit

-161.58%-47.18M

40.88%-118.99M

-11.50%-61.76M

-12.23%-61.61M

-57.92%-72.23M

269.25%76.61M

-9.79%-201.28M

-38.83%-55.39M

-13.33%-54.89M

6.09%-45.73M

Net non-operating interest income expense

-23.02%2.54M

17.71%11.1M

-59.43%1.49M

98.70%3.52M

6.02%2.8M

145.38%3.29M

76.43%9.43M

57.45%3.68M

112.11%1.77M

70.52%2.64M

Non-operating interest income

----

17.71%11.1M

-59.43%1.49M

98.70%3.52M

----

76.43%9.43M

--3.68M

--1.77M

----

Total other finance cost

23.02%-2.54M

----

-6.02%-2.8M

-145.38%-3.29M

----

-70.52%-2.64M

Other net income (expense)

92.57%-4.35M

-155.01M

-296K

-44.8M

-51.35M

-58.57M

Special income (charges)

92.57%-4.35M

---155.01M

---296K

---44.8M

---51.35M

---58.57M

--0

-Less:Impairment of capital assets

-92.57%4.35M

--155.01M

--296K

--44.8M

--51.35M

--58.57M

--0

Income before tax

-329.71%-48.99M

-37.04%-262.9M

-17.12%-60.57M

-93.68%-102.89M

-180.27%-120.77M

148.56%21.33M

-7.79%-191.85M

-37.67%-51.71M

-11.60%-53.13M

8.61%-43.09M

Income tax

-49.48%98K

-1,282.28%-5.07M

-205.02%-272K

4,133.33%1.27M

-7,739.02%-6.26M

234.48%194K

40.20%429K

486.57%259K

-65.12%30K

241.67%82K

Net income

-332.29%-49.09M

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.84%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.48%-43.17M

Net income continuous Operations

-332.29%-49.09M

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.84%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.48%-43.17M

Minority interest income

Net income attributable to the parent company

-332.29%-49.09M

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.85%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.47%-43.17M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-332.29%-49.09M

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.85%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.47%-43.17M

Basic earnings per share

-307.69%-0.27

-18.40%-1.48

-6.25%-0.34

-73.53%-0.59

-127.59%-0.66

143.33%0.13

-1.63%-1.25

-23.08%-0.32

-3.03%-0.34

12.12%-0.29

Diluted earnings per share

-325.00%-0.27

-18.40%-1.48

-6.25%-0.34

-73.53%-0.59

-127.59%-0.66

140.00%0.12

-1.63%-1.25

-23.08%-0.32

-3.03%-0.34

12.12%-0.29

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-99.70%481K	58.34%176.23M	-92.50%2.04M	-64.48%9.4M	-76.73%6.84M	459.52%157.96M	0.54%111.3M	-2.70%27.23M	-7.36%26.46M	5.40%29.38M
Operating revenue	-99.70%481K	58.34%176.23M	-92.50%2.04M	-64.48%9.4M	-76.73%6.84M	459.52%157.96M	0.54%111.3M	-2.70%27.23M	-7.36%26.46M	5.40%29.38M
Cost of revenue
Gross profit
Operating expense	-41.42%47.66M	-5.55%295.22M	-22.77%63.81M	-12.72%71.01M	5.26%79.06M	10.70%81.35M	6.31%312.58M	21.71%82.62M	5.66%81.35M	-1.91%75.11M
Selling and administrative expenses	-35.12%11.77M	-2.42%61.17M	-20.34%13.1M	-14.29%13.92M	6.10%16.01M	21.65%18.14M	-0.85%62.68M	2.23%16.44M	11.98%16.24M	-8.45%15.09M
-General and administrative expense	-35.12%11.77M	-2.42%61.17M	-20.34%13.1M	-14.29%13.92M	6.10%16.01M	21.65%18.14M	-0.85%62.68M	2.23%16.44M	11.98%16.24M	-8.45%15.09M
Research and development costs	-43.22%35.89M	-6.34%234.06M	-23.38%50.71M	-12.33%57.09M	5.04%63.05M	7.91%63.22M	8.27%249.9M	27.76%66.18M	4.19%65.12M	-0.11%60.02M
Operating profit	-161.58%-47.18M	40.88%-118.99M	-11.50%-61.76M	-12.23%-61.61M	-57.92%-72.23M	269.25%76.61M	-9.79%-201.28M	-38.83%-55.39M	-13.33%-54.89M	6.09%-45.73M
Net non-operating interest income expense	-23.02%2.54M	17.71%11.1M	-59.43%1.49M	98.70%3.52M	6.02%2.8M	145.38%3.29M	76.43%9.43M	57.45%3.68M	112.11%1.77M	70.52%2.64M
Non-operating interest income	----	17.71%11.1M	-59.43%1.49M	98.70%3.52M	----	----	76.43%9.43M	--3.68M	--1.77M	----
Total other finance cost	23.02%-2.54M	----	----	----	-6.02%-2.8M	-145.38%-3.29M	----	----	----	-70.52%-2.64M
Other net income (expense)	92.57%-4.35M	-155.01M	-296K	-44.8M	-51.35M	-58.57M
Special income (charges)	92.57%-4.35M	---155.01M	---296K	---44.8M	---51.35M	---58.57M	--0	--0	--0	--0
-Less:Impairment of capital assets	-92.57%4.35M	--155.01M	--296K	--44.8M	--51.35M	--58.57M	--0	--0	--0	--0
Income before tax	-329.71%-48.99M	-37.04%-262.9M	-17.12%-60.57M	-93.68%-102.89M	-180.27%-120.77M	148.56%21.33M	-7.79%-191.85M	-37.67%-51.71M	-11.60%-53.13M	8.61%-43.09M
Income tax	-49.48%98K	-1,282.28%-5.07M	-205.02%-272K	4,133.33%1.27M	-7,739.02%-6.26M	234.48%194K	40.20%429K	486.57%259K	-65.12%30K	241.67%82K
Net income	-332.29%-49.09M	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.84%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.48%-43.17M
Net income continuous Operations	-332.29%-49.09M	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.84%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.48%-43.17M
Minority interest income		0					0
Net income attributable to the parent company	-332.29%-49.09M	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.85%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.47%-43.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-332.29%-49.09M	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.85%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.47%-43.17M
Basic earnings per share	-307.69%-0.27	-18.40%-1.48	-6.25%-0.34	-73.53%-0.59	-127.59%-0.66	143.33%0.13	-1.63%-1.25	-23.08%-0.32	-3.03%-0.34	12.12%-0.29
Diluted earnings per share	-325.00%-0.27	-18.40%-1.48	-6.25%-0.34	-73.53%-0.59	-127.59%-0.66	140.00%0.12	-1.63%-1.25	-23.08%-0.32	-3.03%-0.34	12.12%-0.29
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall